These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28973041)

  • 1. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
    Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
    PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
    Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
    Ollivett TL; Nydam DV; Bowman DD; Zambriski JA; Bellosa ML; Linden TC; Divers TJ
    J Dairy Sci; 2009 Apr; 92(4):1643-8. PubMed ID: 19307646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
    Schnyder M; Kohler L; Hemphill A; Deplazes P
    Vet Parasitol; 2009 Mar; 160(1-2):149-54. PubMed ID: 19062195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
    Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION.
    Abaza BE; Hamza RS; Farag TI; Abdel-Hamid MA; Moustafa RA
    J Egypt Soc Parasitol; 2016 Dec; 46(3):683-692. PubMed ID: 30230765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.
    Viel H; Rocques H; Martin J; Chartier C
    Parasitol Res; 2007 Dec; 102(1):163-6. PubMed ID: 17874133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperazine-Derivative MMV665917: An Effective Drug in the Diarrheic Piglet Model of Cryptosporidium hominis.
    Lee S; Ginese M; Girouard D; Beamer G; Huston CD; Osbourn D; Griggs DW; Tzipori S
    J Infect Dis; 2019 Jun; 220(2):285-293. PubMed ID: 30893435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug treatment and novel drug target against Cryptosporidium.
    Gargala G
    Parasite; 2008 Sep; 15(3):275-81. PubMed ID: 18814694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice.
    Fahmy MA; Abdelaal AA; Hassan SI; Shalaby MA; Ismail MAM; Khairy RA; Badawi MA; Afife AA; Fadl HO
    Rev Bras Parasitol Vet; 2021; 30(4):e012121. PubMed ID: 34852131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of a Cryptosporidium hominis outbreak in a day-care center.
    Vandenberg O; Robberecht F; Dauby N; Moens C; Talabani H; Dupont E; Menotti J; van Gool T; Levy J
    Pediatr Infect Dis J; 2012 Jan; 31(1):10-5. PubMed ID: 22094626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
    Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.
    Blagburn BL; Drain KL; Land TM; Kinard RG; Moore PH; Lindsay DS; Patrick DA; Boykin DW; Tidwell RR
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2877-82. PubMed ID: 9797219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The piglet acute diarrhea model for evaluating efficacy of treatment and control of cryptosporidiosis.
    Lee S; Beamer G; Tzipori S
    Hum Vaccin Immunother; 2019; 15(6):1445-1452. PubMed ID: 30036127
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryptosporidium and Giardia: treatment options and prospects for new drugs.
    Rossignol JF
    Exp Parasitol; 2010 Jan; 124(1):45-53. PubMed ID: 19632225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
    Giacometti A; Burzacchini F; Cirioni O; Barchiesi F; Dini M; Scalise G
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):885-9. PubMed ID: 10691200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus).
    Gargala G; François A; Favennec L; Rossignol JF
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2821-3. PubMed ID: 23478972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic efficacy on
    Diawara EH; François A; Stachulski AV; Razakandrainibe R; Costa D; Favennec L; Rossignol JF; Gargala G
    Parasitology; 2021 Jul; 148(8):975-984. PubMed ID: 33775260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.
    Rossignol JF; Ayoub A; Ayers MS
    J Infect Dis; 2001 Jul; 184(1):103-6. PubMed ID: 11398117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice.
    Madbouly Taha N; Salah A Yousof HA; El-Sayed SH; Younis AI; Ismail Negm MS
    Exp Parasitol; 2017 Oct; 181():57-69. PubMed ID: 28764965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.